Explainer video: Assess- Evaluating Patient Readiness for Diabetes- Management Strategies - Video
Overview
Discussing weight with people living with type 2 diabetes can be difficult, but it is vital to improving care. Many patients with overweight or obesity may feel reluctant to bring up weight or seek support, which is why physicians should approach the topic with sensitivity. Asking for permission to discuss weight in a non-judgmental way helps reduce feelings of stigma or discrimination, which research shows can negatively affect diabetes self-care and increase emotional distress. Patients who feel judged about weight often report poorer interactions with clinicians, higher BMI, and higher HbA1c levels.
When patients are ready, clinicians should explore their weight history, previous attempts, and barriers to weight loss, then set realistic, manageable goals together. Starting with small, collaborative changes in diet, physical activity, or self-care can make weight management more achievable. Thoughtful conversations not only support weight reduction but also improve diabetes outcomes and strengthen patient engagement.
References:
1. American Diabetes Association Professional Practice Committee. 8. Obesity and weight management for the prevention and treatment of type 2 diabetes: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022;45(suppl 1):S113-S124.
2. Potter L, Wallston K, Trief P, et al. Attributing discrimination to weight: associations with well-being, self-care, and disease status in patients with type 2 diabetes mellitus. J Behav Med. 2015;38(6):863-875.
3. Puhl RM, Himmelstein MS, Hateley-Browne JL, et al. Weight stigma and diabetes stigma in U.S. adults with type 2 diabetes: associations with diabetes self-care behaviors and perceptions of health care. Diabetes Res Clin Pract. 2020;168:108387.
Disclaimer:
This material (including any link) is intended solely for the use of the recipient(s) and may contain confidential information. Any unauthorized review, use, disclosure, copying, or distribution is strictly prohibited. If you are not the intended recipient, please notify the sender immediately and destroy all copies of the material. The information provided in this section is intended solely for the use of registered medical practitioner. This material is being provided to healthcare professionals for their guidance and use. Nothing on this website/microsite/material should be construed as giving medical advice or making recommendations regarding any health-related decision or action.
For adverse events and safety reporting, please reach out to: mailbox_in-gps@lilly.com For any additional information related to Lilly products, please reach out to: queries_in-medinfo@lilly.com. For further Information about Lilly and Lilly products please contact us at the below address: Plot 92, Sector 32 Gurgaon, Haryana, 122001 India Ph.: +91-124-4753000/01 | www.lilly.com/in.
PP code - PP-TR-IN-0779 | 06 October 2025
Eli Lilly and Company. All rights reserved.
